+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of the primary biliary cirrhosis and sclerosing cholangitis with ursodeoxycholic acid



Treatment of the primary biliary cirrhosis and sclerosing cholangitis with ursodeoxycholic acid



Journal of Hepatology 25(Suppl. 1): 210




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034071789

Download citation: RISBibTeXText


Related references

Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid. Current Gastroenterology Reports 1(1): 38-41, 2000

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis in pregnancy. Hepatology 36(4 Part 2): 491A, 2002

Urinary excretion of ursodeoxycholic acid during treatment of patients with primary biliary cirrhosis and primary sclerosing cholangitis. Journal of Hepatology 7, 1988

Single dose or multiple doses of ursodeoxycholic acid are equally effective in the treatment of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 108(4 Suppl. ): A1191, 1995

The effect of ursodeoxycholic acid urso in primary sclerosing cholangitis a comparison to primary biliary cirrhosis. Gastroenterology 94(5 Part 2): A595, 1988

Comparative effects of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis and primary sclerosing cholangitis. Clinical Research 37(2): 365A, 1989

Ursodeoxycholic acid therapy plays an immunomodulatory and anti-apoptotic role in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Journal of Hepatology 38(Suppl. 2): 208, 2003

Ursodeoxycholic acid therapy affects the cytokine network and plays an immunomodulatory role in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 36(4 Part 2): 499A, 2002

Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. Journal of Hepatology 23(3): 283-289, 1995

Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis. Internal Medicine 39(12): 1049-1053, 2000

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 40(3): 693-698, 2004

Ursodeoxycholic acid and biliary bile acid composition in primary sclerosing cholangitis Effect of Apo E phenotype. Gastroenterology 123(1 Suppl.): 65, 2002

Effect of ursodeoxycholic acid udca treatment on the biliary secretion of bile acids and bile lipids in primary sclerosing cholangitis psc. Gastroenterology 98(5 Part 2): A637, 1990

Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis. Digestive Diseases and Sciences 51(3): 618-622, 2006

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. New England Journal of Medicine 336(10): 691-695, 1997